Sacrococcygeal Local Anesthesia With Different Doses of Clonidine for Pilonidal Sinus Surgery
NCT ID: NCT02539693
Last Updated: 2022-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2016-10-31
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Given the effectiveness of sacrococcygeal local anesthesia in pilonidal sinus surgery, it would be valuable to study the effect of the local anesthesia with 75µg/mL of clonidine versus 150µg/mL.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest in Clonidine in Association With Levobupivacaine Performing a Pudendal Block in Proctological Surgery.
NCT04530903
Comparison of Chloroprocaine vs Lidocaine for Epidural Anesthesia in Cesarean Delivery
NCT03414359
Does Intraperitoneal Instillation of Lidocaine at Cesarean Delivery Improve Postoperative Analgesia?
NCT02264795
Effect of Local Anesthesia on Postoperative Pain Following Sacrospinous Ligament Fixation
NCT02890199
Intravenous Lidocaine Infusion in the Management of Post-operative Pain in Colorectal Patients
NCT01836614
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a prospective study with a randomized double-blind design that will be conducted between October 2015 and October 2016.
Patients scheduled for pilonidal sinus surgery will be included. Patients will be randomly distributed to one of 2 groups with 30 patients in each, using the sealed envelope technique. Group one will receive sacrococcygeal local anesthesia with 75µg/mL of clonidine, while group two will receive sacrococcygeal local anesthesia with 150µg/mL of clonidine.
Anesthetic techniques
Being a double-blinded study, a specialized nurse will prepare the syringes for each patient.
Sacrococcygeal local anesthesia technique
The Sacrococcygeal block will be performed with the patient in the prone position. Four injection sites are marked on the skin after aseptic preparation.
The sites are placed as follows: 4 cm below and above the pilonidal sinus and 3 cm lateral to its center on both sides. Therefore a "lozenge" is formed by connecting the 4 sites.
At first, an injection of 0.3 ml lidocaine 1% is injected at each site using an 8-mm 30G needle. Then 4 injections are admitted to each of the 4 injection sites in turn, with equal supply of the anesthetic mixture in the following manner: a 10-mm 27G needle containing the anesthetic mixture is introduced perpendicularly to the skin and the mixture is infiltrated. The needle is partially withdrawn and reinserted at 45 degrees to the skin aiming towards the center of the pilonidal sinus and an injection will be performed. Then the needle is partially withdrawn again and reinserted at an angle of 45 degrees to the skin aiming at one side of the lozenge then at the other side where injections are done.
In case of a multiple pilonidal orifices, a hexagon is done. These sites are then anesthetized as previously described.
Anesthetic mixture
For group 1, the syringe will contain: lidocaine 2% 14 mL, bupivacaine 0.5% 5 mL, and clonidine 0.5 mL with 0.5 mL of saline (thus 75 µg/mL).
As for group 2, the syringes will contain: lidocaine 2% 14 mL, bupivacaine 0.5% 5 mL, and clonidine 1 mL (thus 150 µg/mL).
Depending on each patient's weight and type of pilonidal sinus, the anesthetic mixture might vary from 30 to 40 mL in total.
Data collection
Demographic data, type and duration of surgery will be recorded. Haemodynamics will be registered at all times (pre-operatively, intra-operatively and post-operatively).
Pain will be assessed using VNRS with 0 being no pain and 10 maximum pain for 48 hours post-operatively.
As for postoperative analgesia consumption, patients with a VNRS score less than 3 are given paracetamol 1000 mg each 8 hours. If VNRS is between three and four, patients are given Tramadol Hydrochloride 50-100 mg every 4- 6 hours and if the VNRS score is greater or equal to five, patients receive 1 mg/kg Dolosal.
Return to normal activity will be defined by the ability to sit, walk and work comfortably and will be assessed by calling the patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clonidine 75
Patients will receive sacrococcygeal local anesthesia with 75µg/mL of clonidine. The anesthetic mixture will contain: lidocaine 2% 14 mL, bupivacaine 0.5% 5 mL, and clonidine 0.5 mL with 0.5 mL of saline (thus 75 µg/mL).
Clonidine 75 µg/mL in sacrococcygeal block
Sacrococcygeal block will be performed using 75 µg/mL clonidine in the anesthetic mixture
Lidocaine
3 ml lidocaine 1% is injected at each block site
Pilonidal sinus
Removal of pilonidal sinus
Clonidine 150
Patients will receive sacrococcygeal local anesthesia with 150µg/mL of clonidine. The anesthetic mixture will contain: lidocaine 2% 14 mL, bupivacaine 0.5% 5 mL, and clonidine 1 mL (thus 150 µg/mL).
Clonidine 150 µg/mL in sacrococcygeal block
Sacrococcygeal block will be performed using 150 µg/mL clonidine in the anesthetic mixture
Lidocaine
3 ml lidocaine 1% is injected at each block site
Pilonidal sinus
Removal of pilonidal sinus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clonidine 75 µg/mL in sacrococcygeal block
Sacrococcygeal block will be performed using 75 µg/mL clonidine in the anesthetic mixture
Clonidine 150 µg/mL in sacrococcygeal block
Sacrococcygeal block will be performed using 150 µg/mL clonidine in the anesthetic mixture
Lidocaine
3 ml lidocaine 1% is injected at each block site
Pilonidal sinus
Removal of pilonidal sinus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Makassed General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zoher Naja
Chairperson of Anesthesia and Pain Management Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zoher Naja, MD
Role: PRINCIPAL_INVESTIGATOR
Makassed General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Makassed General Hospital
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
082015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.